Merit Medical (MMSI) Systems announced a significant milestone for breast cancer treatment: SCOUT Radar Localization use has reached 750,000 patients worldwide. Radar localization helps physicians surgically remove abnormal breast tissue while reducing trauma to surrounding healthy tissue. By implanting a tiny reflector, approximately the size of a grain of rice, physicians can use SCOUT to target affected tissue within +/- 1 mm of accuracy, which may result in more successful surgeries and improved patient care.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical Systems: Promising Growth Potential Driven by Innovation, Strategic Acquisitions, and Strong Financials
- Merit Medical announces first patient enrolled WRAP North America registry
- Merit Medical Systems: Strong Performance, Strategic Growth, and Positive Outlook Justify Buy Rating
- Merit Medical launches Prelude Wave Hydrophilic Sheath Introducer
- Merit Medical Systems: Strong Performance and Strategic Growth Drive Buy Rating Despite Reimbursement Challenges